Fresenius Medical Ownership
| FMS Stock | USD 21.39 0.09 0.42% |
Shares in Circulation | First Issued 1997-03-31 | Previous Quarter 293.4 M | Current Value 587 M | Avarage Shares Outstanding 567 M | Quarterly Volatility 198.9 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Fresenius |
Fresenius Stock Ownership Analysis
The company has price-to-book (P/B) ratio of 0.86. Some equities with similar Price to Book (P/B) outperform the market in the long run. Fresenius Medical Care has Price/Earnings To Growth (PEG) ratio of 0.43. The entity last dividend was issued on the 17th of May 2024. The firm had 2:1 split on the 4th of December 2012. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany. Fresenius Medical is traded on New York Stock Exchange in the United States. To learn more about Fresenius Medical Care call FACHE MBA at 49 6172 609 0 or check out https://www.freseniusmedicalcare.com.Besides selling stocks to institutional investors, Fresenius Medical also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Fresenius Medical's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Fresenius Medical's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Fresenius Medical Quarterly Liabilities And Stockholders Equity |
|
Fresenius Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Fresenius Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Fresenius Medical Care backward and forwards among themselves. Fresenius Medical's institutional investor refers to the entity that pools money to purchase Fresenius Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Citadel Advisors Llc | 2024-06-30 | 99.2 K | Geode Capital Management, Llc | 2024-06-30 | 93.8 K | Settian Capital. Lp | 2024-06-30 | 90 K | Jane Street Group Llc | 2024-06-30 | 86.1 K | Triasima Portfolio Management Inc | 2024-06-30 | 85.4 K | Fmr Inc | 2024-06-30 | 83.6 K | Nuveen Asset Management, Llc | 2024-06-30 | 78.3 K | Ci Private Wealth Llc | 2024-06-30 | 75.1 K | Franklin Resources Inc | 2024-06-30 | 72.3 K | Pzena Investment Management, Llc | 2024-06-30 | 16.2 M | Fiduciary Management, Inc. Of Milwaukee | 2024-06-30 | 5.2 M |
Fresenius Medical's latest congressional trading
Congressional trading in companies like Fresenius Medical Care, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Fresenius Medical by those in governmental positions are based on the same information available to the general public.
| 2019-02-08 | Representative Greg Gianforte | Acquired $100K to $250K | Verify | ||
| 2018-07-09 | Representative Greg Gianforte | Acquired $15K to $50K | Verify |
Fresenius Medical Outstanding Bonds
Fresenius Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Fresenius Medical Care uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Fresenius bonds can be classified according to their maturity, which is the date when Fresenius Medical Care has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| FRESLN 425 02 OCT 50 Corp BondUS358070AB61 | View | |
| FMEGR 475 15 OCT 24 Corp BondUS35802XAJ28 | View | |
| FMEGR 375 15 JUN 29 Corp BondUS35805BAA61 | View | |
| FMEGR 2375 16 FEB 31 Corp BondUS35805BAB45 | View | |
| FMEGR 1875 01 DEC 26 Corp BondUS35805BAC28 | View | |
| FMEGR 3 01 DEC 31 Corp BondUS35805BAE83 | View |
Fresenius Medical Corporate Filings
6K | 5th of November 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
| 28th of June 2024 Other Reports | ViewVerify | |
| 28th of May 2024 Other Reports | ViewVerify | |
13A | 13th of February 2024 An amended filing to the original Schedule 13G | ViewVerify |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Fresenius Stock Analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.